Eli Lilly and Co
Stocks making the biggest moves midday: Pfizer, Nike, Conagra, Corteva, GEO Group, Tesla, Reddit and more
Check out the companies making the biggest moves midday: Drug stocks — Shares of drugmakers rallied a second day as investors bet the industry will strike more deals with the Trump administration. On Tuesday, Pfizer received a three-year exemption to tariffs in exchange for investing in domestic manufacturing and discounting drug prices for Medicaid patients. Pfizer […]
Read More
Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. Win Mcnamee | Getty Images President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not […]
Read More
Healthy Returns: Pfizer’s new obesity bet, Metsera, releases encouraging data on lead drug
Thomas Fuller | SOPA Images | Lightrocket | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Pfizer‘s newest bet on obesity is already showing promise. The company last week said it would buy […]
Read More
Stocks making the biggest moves midday: Boeing, Paccar, Intel, Mirion Tech and more
Check out the companies making the biggest moves midday: Paccar — The maker of Peterbilt trucks jumped 5% after President Donald Trump slapped a 25% tariff on imported heavy trucks starting Oct. 1. Boeing – The aircraft maker rallied more than 4% after Turkish Airlines ordered 75 Boeing 787 aircraft and said it completed negotiations […]
Read More
Stocks making the biggest premarket moves: Paccar, Intel, RH, Riot Platforms and more
Check out the companies making the biggest moves in premarket trading: Paccar — The maker of Peterbilt trucks jumped 7% after President Donald Trump said slapped a 25% tariff on imported heavy trucks starting Oct. 1. Intel — The chip company added 4.4%. The Wall Street Journal reported Intel has approached Apple , Taiwan Semiconductor […]
Read More
Roche targets becoming top 3 obesity player as experimental drug enters late-stage trial
The Roche Holding AG headquarters on April 11, 2025, in Basel, Switzerland. Sedat Suna | Getty Images News | Getty Images Swiss pharmaceutical firm Roche is targeting becoming a top three obesity player globally, posing a potential rival to heavyweights Novo Nordisk and Eli Lilly as it advances one of its experimental weight-loss drugs to […]
Read More
Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs
A rendering of Eli Lilly’s manufacturing facility in Houston, Texas. Courtesy: Eli Lilly Eli Lilly on Tuesday said it will spend $6.5 billion to build a manufacturing facility in Houston, Texas, to boost production of the company’s pipeline of so-called small molecule drugs, including its closely watched experimental obesity pill. It is the second in […]
Read More
Pfizer boosts obesity drug prospects with $7.3 billion deal to buy Metsera
Thomas Fuller | SOPA Images | Lightrocket | Getty Images Pfizer on Monday said it would buy weight loss drugmaker Metsera in an up to $7.3 billion deal, including future payments, as it scrambles to win a slice in the booming obesity drug market. Pfizer said it will pay an initial $47.50 a share in […]
Read More
Novo Nordisk shares pop 5% after Wegovy pill trial shows ‘significant’ weight reduction
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic and Wegovy are pictures while the company presents the annual report at Novo Nordisk in Bagsvaerd, Denmark, on February 5, 2025. Mads Claus Rasmussen | Afp | Getty Images Novo Nordisk said Wednesday that late-stage trial results […]
Read More
Eli Lilly pill outperforms Novo Nordisk’s oral drug in head-to-head diabetes trial
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly on Wednesday said its experimental pill outperformed Novo Nordisk‘s own oral drug in the first head-to-head study comparing the two medicines in patients with Type 2 diabetes. The […]
Read More